RSP Systems A/S is located in Odense, Denmark, where it was founded in 2006 as a spin-out from the Biophotonics Group at the University of Southern Denmark (SDU). Today, the company employs a small organization. It leverages resources by partly outsourcing development activities to an established network of suppliers and partners all over the world.
RSP Systems A/S was initially funded by Danish venture capital funds (Syddansk Kapital and Syddansk Teknologisk Innovation), but was in 2011 acquired by private European investors.
Anders Weber, Acting CEO
Over time, Anders has engaged in several successful MedTech companies as an academic researcher, inventor, manager and venture investor. Much of this activity in the diabetes field. He has been a consultant for Eli Lilly’s advanced glucose sensor initiative. Additionally he has acted as technology scout for Radiometer (now part of Danaher) on new technology for glucose measurement, and the chairman of the Swiss company Solianis AG (now part of Biovotion), introducing a multisensor wearable device for diabetes monitoring.The list of companies co-founded by Anders includes Precisense A/S (now part of Medtronics), introducing a competitive assay sensor format for glucose monitoring, and Retinalyze A/S, introducing computer assisted image analysis for assessing diabetic retinopathy.MSc in Food Science and PhD in Immunology from the Royal Veterinary and Agricultural University of Denmark.
Stefan O. Banke, CTO
Stefan co-founded RSP Systems in 2006 and serves as the company’s Chief Technical Officer. During his years at RSP Systems, Stefan has obtained extensive hands-on and management expertise within all aspects of the company’s activities. These include optical system design and construction, advanced data analysis, biological- and medical aspects of glucose monitoring, as well as IPR management.
Prior to co-founding RSP Systems, Stefan worked on Raman spectroscopy and optical physics as a Research Assistant at the Biophotonics Group, University of Southern Denmark.
MSc. in Optical Physics from the University of Southern Denmark.
Board of Directors
Jens U. Holst, Chairman of the Board
Bringing more than 20 years of experience from international banking and from the MedTech industry to RSP.
During his banking career, Jens held senior management positions in Norway (DNB) and Switzerland.
In 1987, Jens co-founded the Danish IVF MedTech company Origio (formerly MediCult), and from 1995 to 2010 he served as chairman of the company, which was listed on the Oslo Stock Exchange in 1996.
Currently an active owner in several smaller, Scandinavian healthcare companies, among them RSP Systems, where Jens is co-owner and chairman since May 2011.
MBA from the University of Mannheim.
Michael Obermayer, Board Member
Fjord Capital Partners was co‐founded by Muchael in 2007. Prior to that, Michael spent 28 years with McKinsey & Company, covering more than 300 engagements with many Fortune 100 International corporations.
In addition to being Managing Partner of Fjord, Michael is furthermore a Member of the supervisory boards of Pöyry plc, Euram Bank AG, Nilar International AB and BioGasol ApS.
MSc Chemistry from Royal Institute of Technology, Stockholm, DSc in Biochemistry and Biophysics from Ludwig Maximilian University, Munich, MBA from INSEAD, Fontainebleau.
Georg von Werz, Board Member
Georg is an experienced investor in property and private equity in Europe, North America and Asia.
He co-founded TMW Real Estate Group, a leading institutional property investment manager. During his 30 years as CEO, he grew the group into a global enterprise investing on behalf of major insurers, pension funds and banks, and led the merger of TMW with the international real estate arm of Prudential/Pramerica.
He is an activist investor in private equity with a focus on resource efficiency and life sciences, and he serves on a number of advisory boards.
Law degree from Ludwig Maximilian University, Munich.
Robert von Werz, Board Member
Partner at Fjord Capital Partners, where he brings deep transactional and operational experience from 15 years of investing and driving growth on both sides of the Atlantic. Prior to Fjord Capital Partner, he led the successful buyout of Discovery Networks Germany from KirchMedia, subsequently taking over the company’s business development and sales activities and and successfully growing the company. Robert holds a BSc. in Law and Government from the London School of Economics, MBA from Columbia Business School.
Roland Berger, Board Member
Prof. Dr. h.c. Roland Berger is Founder of the strategy consultancy Roland Berger and has been the company’s Honorary Chairman since 2010. From the company’s foundation in 1967 until 2003, Roland Berger was CEO of the firm. Until 2010 he also held the position as Chairman of the Supervisory Board.
Roland Berger is a member of several supervisory boards and advisory councils of national and international companies, foundations and organizations and an active investor in many private and listed companies as well as startups around the world.
He is also Chairman of the Board of Trustees of the Roland Berger Foundation, which is dedicated to the global protection of human dignity and helps gifted children and young people from underprivileged families to gain access to the best possible primary and secondary education.
MBA from Ludwig Maximilian University, Munich.
Jacob L. Philipsen, Board Member
Bringing to RSP 15 years of executive management experience. Primarily from high-tech companies operating in the fields of medical devices, optics, sensors, and electronics. From 2013 to 2016 he served as the CEO of RSP Systems.
Prior to joining RSP Systems in 2013, Jacob spent three years as CEO of Flux A/S. Flux A/S manufactures customized components for industrial and space electronics, and hold facilities in Denmark and Thailand.
From 2003 to 2010, Jacob also headed a corporate venture in the Sonion group. Here he built up a division with activities in Denmark and Vietnam. This division manufactured the world’s first digital MEMS microphones for mobile phones and hearing aids. Before, Jacob worked in engineering, marketing, and management positions in France and Denmark, supplying optical components for telecommunications.
PhD and MSc in Engineering from the Technical University of Denmark.
Stig Visti Andersen, Business Consultant
Has held numerous senior management position in MedTech start-ups developing new disruptive technologies. Stig came to RSP Systems after three years as CEO for Acarix A/S, a cardiovascular diagnostic company, based in Copenhagen. Prior to this he was Vice President Global Sales & Marketing at Sensimed AG, an ophthalmic diagnostic company in Lausanne, Switzerland. Before that Stig was Vice President European Operations for Glaukos Corporation a US MedTech startup that pioneered the development of minimal invasive glaucoma implants (MIGS).
Stig has also co-founded a MedTech consulting company in Belgium catering to international clients and been involved amongst other in two start-ups in France.
Early in his career he held various positions at Eli Lilly in Marketing, Sales and Business Development. Starting in Copenhagen then Geneva and finally in Brussels as Managing Director Europe for Interventional Cardiology where he built and led an independent Business Unit with sales across all of Europe.
He holds a Master of Science degree in Economics (Cand Merc) from the University of Aarhus
Dr. Karl Dietrich Hepp, Advisor
Karl Dietrich is a leading endocrinologist and diabetologist. He was head of the 3rd Dept. of Medicine and Diabetes Unit at the Academic Hospital München-Bogenhausen.
Karl Dietrich is one of the pioneers of the insulin pump. The first miniaturized model developed with Siemens Corp., published in 1967. Further worked on implantable insulin pumps and glucose feedback regulation.
He was Honorary Secretary of EASD (European Association for the Study of Diabetes), and President of the German Diabetes Association. Karl Dietrich has received several international awards in the field of diabetes.
MD from the University of Munich.